Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-24 @ 1:00 PM
NCT ID:
NCT00634361
Brief Summary:
This is an open-label trial of an omega-3 fatty acid for symptoms of the schizophrenia prodrome.
Study:
NCT00634361
Study Brief:
Protocol Section:
NCT00634361